Gallego S - Search Results

1

Post-transplant lymphoproliferative disorders in children: the role of chemotherapy in the era of rituximab.

Gallego S, Llort A, Gros L, Sanchez de Toledo J Jr, Bueno J, Moreno A, Nieto J, Sanchez de Toledo J. Gallego S, et al. Pediatr Transplant. 2010 Feb;14(1):61-6. doi: 10.1111/j.1399-3046.2009.01181.x. Epub 2009 Mar 31. Pediatr Transplant. 2010. PMID: 19344338

2

Improving survival of medulloblastoma: results in two groups of patients.

Giralt J, Sánchez de Toledo J, Moraga F, Poch JM, Gallego S, Roselló J, Maldonado X, Prats J. Giralt J, et al. Among authors: gallego s. Oncology. 1996 Jan-Feb;53(1):38-42. doi: 10.1159/000227532. Oncology. 1996. PMID: 8570129

3

Differential polymerase chain reaction with serial dilutions for quantification of MYCN gene amplification in neuroblastoma.

Gallego S, Reventos J, Sanchez de Toledo J, Munell F. Gallego S, et al. Anticancer Res. 1998 Mar-Apr;18(2A):1211-5. Anticancer Res. 1998. PMID: 9615790

4

Clinical relevance of molecular markers in neuroblastoma: results from a single institution.

Gallego S, Parareda A, Munell F, Sanchez de Toledo J, Reventos J. Gallego S, et al. Oncol Rep. 1999 Jul-Aug;6(4):891-6. doi: 10.3892/or.6.4.891. Oncol Rep. 1999. PMID: 10373677

5

New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma.

Parareda A, Villaescusa JC, Sanchez de Toledo J, Gallego S. Parareda A, et al. Among authors: gallego s. Neurosci Lett. 2003 Jan 9;336(1):29-32. doi: 10.1016/s0304-3940(02)01220-x. Neurosci Lett. 2003. PMID: 12493595

6

[Neuroblastoma: biological markers, surgery, and clinical course].

Martínez Ibáñez V, Abad P, Gallego S, Sánchez de Toledo J, Marqués A, Boix Ochoa J. Martínez Ibáñez V, et al. Among authors: gallego s. Cir Pediatr. 2000 Apr;13(2):47-53. Cir Pediatr. 2000. PMID: 12602001 Spanish.

7

Expression of multidrug resistance-1 and multidrug resistance-associated protein genes in pediatric rhabdomyosarcoma.

Gallego S, Llort A, Parareda A, Sanchez De Toledo J. Gallego S, et al. Oncol Rep. 2004 Jan;11(1):179-83. Oncol Rep. 2004. PMID: 14654923

8

Prognostic impact of the detection of microcirculating tumor cells by a real-time RT-PCR assay of tyrosine hydroxylase in patients with advanced neuroblastoma.

Parareda A, Gallego S, Roma J, Llort A, Sábado C, Gros L, De Toledo JS. Parareda A, et al. Among authors: gallego s. Oncol Rep. 2005 Oct;14(4):1021-7. Oncol Rep. 2005. PMID: 16142367

9

Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.

Gallego S, Llort A, Roma J, Sabado C, Gros L, de Toledo JS. Gallego S, et al. J Cancer Res Clin Oncol. 2006 Jun;132(6):356-62. doi: 10.1007/s00432-006-0083-y. Epub 2006 Jan 25. J Cancer Res Clin Oncol. 2006. PMID: 16435141

10

Characterisation of novel splicing variants of the tyrosine hydroxylase C-terminal domain in human neuroblastic tumours.

Roma J, Saus E, Cuadros M, Reventós J, Sánchez de Toledo J, Gallego S. Roma J, et al. Among authors: gallego s. Biol Chem. 2007 Apr;388(4):419-26. doi: 10.1515/BC.2007.041. Biol Chem. 2007. PMID: 17391063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters